MacroGenics Inc
Change company Symbol lookup
Select an option...
MGNX MacroGenics Inc
BCH Banco de Chile
NLRCF Northern Lights Resources Corp
ABM ABM Industries Inc
LVOXW LiveVox Holding Equity Warrants Exp 18 June 2026 *W EXP 06/18/2026
TY- Tri-Continental Corp
BAC Bank of America Corp
KLXE KLX Energy Services Holdings Inc
OBNK Origin Bancorp Inc
SNDR Schneider National Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

MacroGenics, Inc. is a biopharmaceutical company that is focused on developing and commercializing antibody-based therapeutics for the treatment of cancer. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is MGC018, an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. It is also developing enoblituzumab, an Fc-optimized monoclonal antibody (mAb) that targets B7-H3 and molecules that target programmed cell death protein 1 (PD-1), a protein that is important in the regulation of the immune system's response to cancer. Its clinical pipeline includes two bispecific DART product candidates that co-engage both PD-1 and lymphocyte-activation gene 3 (LAG-3) (tebotelimab), and PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (lorigerlimab). In addition, it is also developing MGD024.

Closing Price
$3.05
Day's Change
0.10 (3.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.09
Day's Low
2.91
Volume
(Light)
Volume:
661,862

10-day average volume:
2,512,082
661,862
  • Prev Close
    2.95
  • Today's Open
    2.95
  • Day's Range
    2.91-3.09
  • Avg Vol (10-day)
    2.5M
  • Last (time)
    4:00p ET 07/01/22
  • Last (size)
    2
  • 52-Wk Range
    2.13 - 29.16
    LowHigh
  • (07/02/21 - 06/16/22)
    43.19%
  • 78.0%
  • Market Cap
    187.1M
  • Shares Outstanding
    61.3M
  • -3.56
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.1
  • 97.20
  • (% of float 06/15/22)
    13.32

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.